|
1
|
Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al: American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bergin ART and Loi S: Triple-negative breast cancer: Recent treatment advances. F1000Res. 8:F10002019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharma P: Biology and management of patients with triple-negative breast cancer. Oncologist. 21:1050–1062. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA: Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yao H, He G, Yan S, Chen C, Song L, Rosol TJ and Deng X: Triple-negative breast cancer: Is there a treatment on the horizon? Oncotarget. 8:1913–1924. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pickup MW, Mouw JK and Weaver VM: The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 15:1243–1253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Satoh K, Hata M and Yokota H: A novel member of the leucine-rich repeat superfamily induced in rat astrocytes by beta-amyloid. Biochem Biophys Res Commun. 290:756–762. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, et al: LRRC15 Is a novel mesenchymal protein and stromal target for antibody-drug conjugates. Cancer Res. 78:4059–4072. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ben-Ami E, Perret R, Huang Y, Courgeon F, Gokhale PC, Laroche-Clary A, Eschle BK, Velasco V, Le Loarer F, Algeo MP, et al: LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications. Cancers (Basel). 12:122020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, et al: Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 66:5278–5286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rahman FU, Ali A, Khan IU, Duong HQ, Guo R, Wang H, Li ZT and Zhang DW: Novel phenylenediamine bridged mixed ligands dimetallic square planner Pt(II) complex inhibits MMPs expression via p53 and caspase-dependent signaling and suppress cancer metastasis and invasion. Eur J Med Chem. 125:1064–1075. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eiseler T, Döppler H, Yan IK, Goodison S and Storz P: Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res. 11:R132009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Liu M, Wang S, He Y, Huo Y, Yang Z and Cao X: Alantolactone induces apoptosis and suppresses migration in MCF 7 human breast cancer cells via the p38 MAPK, NF κB and Nrf2 signaling pathways. Int J Mol Med. 42:1847–1856. 2018.PubMed/NCBI
|
|
14
|
Khan M, Muzumdar D and Shiras A: Attenuation of tumor suppressive function of FBXO16 ubiquitin ligase activates Wnt signaling in glioblastoma. Neoplasia. 21:106–116. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang F, Cui JY, Gao HF, Yu H, Gao FF, Chen JL and Chen L: Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis. Future Oncol. 16:2619–2633. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mariani A, Wang C, Oberg AL, Riska SM, Torres M, Kumka J, Multinu F, Sagar G, Roy D, Jung DB, et al: Genes associated with bowel metastases in ovarian cancer. Gynecol Oncol. 154:495–504. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Klein A, Olendrowitz C, Schmutzler R, Hampl J, Schlag PM, Maass N, Arnold N, Wessel R, Ramser J, Meindl A, et al: Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett. 276:212–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou J, Wang XH, Zhao YX, Chen C, Xu XY, Sun Q, Wu HY, Chen M, Sang JF, Su L, et al: Cancer-associated fibroblasts correlate with tumor-associated macrophages infiltration and lymphatic metastasis in triple negative breast cancer patients. J Cancer. 9:4635–4641. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Houthuijzen JM and Jonkers J: Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Rev. 37:577–597. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Paolillo M and Schinelli S: Extracellular Matrix Alterations in Metastatic Processes. Int J Mol Sci. 20:202019. View Article : Google Scholar
|
|
21
|
Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res. 92:827–839. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pittayapruek P, Meephansan J, Prapapan O, Komine M and Ohtsuki M: Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int J Mol Sci. 17:172016. View Article : Google Scholar
|
|
23
|
Qin H, Liu X, Li F, Miao L, Li T, Xu B, An X, Muth A, Thompson PR, Coonrod SA, et al: PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling. Cancer Lett. 409:30–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Satriyo PB, Bamodu OA, Chen JH, Aryandono T, Haryana SM, Yeh CT and Chao TY: Cadherin 11 inhibition downregulates β-catenin, deactivates the canonical WNT signalling pathway and suppresses the cancer stem cell-like phenotype of triple negative breast cancer. J Clin Med. 8:82019. View Article : Google Scholar
|
|
25
|
Zhu X, Wang K, Zhang K, Xu F, Yin Y, Zhu L and Zhou F: Galectin-1 knockdown in carcinoma-associated fibroblasts inhibits migration and invasion of human MDA-MB-231 breast cancer cells by modulating MMP-9 expression. Acta Biochim Biophys Sin (Shanghai). 48:462–467. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwon YJ, Leibovitch BA, Bansal N, Pereira L, Chung CY, Ariztia EV, Zelent A, Farias EF and Waxman S: Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells. Oncotarget. 8:88421–88436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lv ZD, Yang ZC, Liu XP, Jin LY, Dong Q, Qu HL, Li FN, Kong B, Sun J, Zhao JJ, et al: Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer. J Cell Mol Med. 20:1640–1650. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jamieson C, Sharma M and Henderson BR: Targeting the β-catenin nuclear transport pathway in cancer. Semin Cancer Biol. 27:20–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Samimi H, Haghpanah V, Irani S, Arefian E, Sohi AN, Fallah P and Soleimani M: Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor ‘BI-847325’ on anaplastic thyroid carcinoma. Daru. 27:1–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu FI, Sun YH, Wei CY, Thisse C and Thisse B: Tissue-specific derepression of TCF/LEF controls the activity of the Wnt/β-catenin pathway. Nat Commun. 5:53682014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Barua D and Hlavacek WS: Modeling the effect of APC truncation on destruction complex function in colorectal cancer cells. PLOS Comput Biol. 9:e10032172013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Karami S, Lin FM, Kumar S, Bahnassy S, Thangavel H, Quttina M, Li Y, Ren J and Bawa-Khalfe T: Novel SUMO-protease SENP7S regulates β-catenin signaling and mammary epithelial cell transformation. Sci Rep. 7:464772017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arnold HK, Zhang X, Daniel CJ, Tibbitts D, Escamilla-Powers J, Farrell A, Tokarz S, Morgan C and Sears RC: The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. EMBO J. 28:500–512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Morrow KA, Das S, Meng E, Menezes ME, Bailey SK, Metge BJ, Buchsbaum DJ, Samant RS and Shevde LA: Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer. Oncotarget. 7:17991–18005. 2016. View Article : Google Scholar : PubMed/NCBI
|
